Literature DB >> 6932046

Characterization of neurotensin production by a line of rat medullary thyroid carcinoma cells.

F N Zeytinoğlu, R F Gagel, A H Tashjian, R A Hammer, S E Leeman.   

Abstract

The rMTC 6-23 cell line was derived from a calcitonin-producing rat medullary thyroid carcinoma. During characterization of these cells we discovered that they also synthesize and secrete neurotensin (NT), a tridecapeptide originally isolated from the hypothalamus and not previously associated with C cells. Immunoreactive NT (iNT) was measured with two antisera: HC-8, which recognizes the COOH-terminal eight amino acids, and TG-1, which binds the NH2-terminal region of NT. By use of these antisera, 2 M acetic acid extracts of rMTC 6-23 cells were found to contain 0.7--5.0 pmol of iNT per mg of cell protein. Successive fractionation of iNT from cell extracts by gel filtration, ion-exchange chromatograpy, and reverse-phase high-pressure liquid chromatography showed at each step a peak of iNT that was indistinguishable from synthetic NT in its chromatographic behavior. Biologic activity of the iNT was confirmed by demonstrating the characteristic fall in arterial blood pressure in the rat after intravenous injection of material purified from rMTC 6-23 cells. Calcium (0.5--4.0 mM) stimulated release of iNT in a dose-dependent manner; the effect was maximal at 3--4 mM calcium. K+ (50 mM) stimulated release of iNT that was maximal in the presence of 1.0--1.5 mM calcium. Synthesis and secretion of iNT by these cells were shown during a 16-day growth experiment. These results demonstrate that rMTC 6-23 cells contain NT and suggest the possibility of an association between neurotensin and calcitonin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932046      PMCID: PMC349695          DOI: 10.1073/pnas.77.6.3741

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma.

Authors:  T Shibasaki; L Deftos; R Guillemin
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

2.  Adrenocorticotropin and calcitonin in medullary thyroid carcinoma: frequency of occurrence and localization in the same cell type by immunocytochemistry.

Authors:  D Goltzman; S N Huang; C Browne; S Solomon
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

3.  Self-regulation of adrenocorticotropin secretion by mouse pituitary tumor cells in culture.

Authors:  U I Richardson
Journal:  Endocrinology       Date:  1978-03       Impact factor: 4.736

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells.

Authors:  C Capella; C Bordi; G Monga; R Buffa; P Fontana; S Bonfanti; G Bussolati; E Solcia
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-02-10

6.  Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities.

Authors:  J C Birkenhäger; G V Upton; H J Seldenrath; D T Krieger; A H Tashjian
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

7.  Transplantable calcitonin-secreting medullary carcinomas of the thyroid in the WAG-Rij rat.

Authors:  G A Boorman; J N Heersche; C F Hollander
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

8.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

9.  Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro.

Authors:  L L Iversen; S D Iversen; F Bloom; C Douglas; M Brown; W Vale
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

10.  Isolation of human intestinal neurotensin.

Authors:  R A Hammer; S E Leeman; R Carraway; R H Williams
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

  10 in total
  7 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin.

Authors:  R J Deschenes; L J Lorenz; R S Haun; B A Roos; K J Collier; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

3.  Neurotensin and medullary carcinoma of the thyroid gland.

Authors:  I Baća; H Schmidt-Gayk
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.

Authors:  J N Bidard; F de Nadai; C Rovere; D Moinier; J Laur; J Martinez; J C Cuber; P Kitabgi
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

5.  Medullary thyroid carcinoma in female BALB/c mice. A report of 3 cases with ultrastructural, immunohistochemical, and transplantation data.

Authors:  M J Van Zwieten; C H Frith; A L Nooteboom; H J Wolfe; R A Delellis
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

6.  SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.

Authors:  Terry W Moody; Daniel C Chan; Samuel A Mantey; Paola Moreno; Robert T Jensen
Journal:  Life Sci       Date:  2014-02-02       Impact factor: 5.037

7.  Neurotensin in human small cell lung carcinoma.

Authors:  M Goedert; J G Reeve; P C Emson; N M Bleehen
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.